Literature DB >> 23788726

Disruption of mycobactin biosynthesis leads to attenuation of Mycobacterium tuberculosis for growth and virulence.

P Vineel Reddy1, Rupangi Verma Puri, Priyanka Chauhan, Ritika Kar, Akshay Rohilla, Aparna Khera, Anil K Tyagi.   

Abstract

BACKGROUND: Low iron availability in the host upregulates the mbt gene cluster of Mycobacterium tuberculosis, which is responsible for mycobactin biosynthesis. However, the biological significance of mycobactins in the growth of this pathogen and in disease progression has not been elucidated.
METHODS: We have disrupted the mbtE gene (Rv2380c) in the mbt cluster to evaluate the importance of mycobactin biosynthesis in the growth and virulence of M. tuberculosis.
RESULTS: The mbtE mutant (MtbΔmbtE) was unable to synthesize mycobactins, displayed an altered colony morphology, and was attenuated for growth in broth culture and in macrophages. Transmission electron microscopy revealed that MtbΔmbtE displayed an altered cell wall permeability. The growth characteristics and colony morphology of MtbΔmbtE were similar to wild type when the medium was supplemented with mycobactins or when MtbΔmbtE was genetically complemented with the mbtE gene. Moreover, guinea pigs infected with MtbΔmbtE exhibited a significantly reduced bacillary load and histopathological damage in the organs, in comparison to M. tuberculosis-infected animals.
CONCLUSIONS: This study highlights the importance of mycobactins in the growth and virulence of M. tuberculosis and establishes the enzymes of mycobactin biosynthesis as novel targets for the development of therapeutic interventions against tuberculosis.

Entities:  

Keywords:  Mycobacterium tuberculosis; drug targets; gene disruption; mycobactins; pathogenesis

Mesh:

Substances:

Year:  2013        PMID: 23788726     DOI: 10.1093/infdis/jit250

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  57 in total

1.  Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis.

Authors:  Pushpendra Singh; Andrej Benjak; Verena J Schuenemann; Alexander Herbig; Charlotte Avanzi; Philippe Busso; Kay Nieselt; Johannes Krause; Lucio Vera-Cabrera; Stewart T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

2.  Organ pathology in the absence of bacteria?

Authors:  Christopher M Jones; Michael Niederweis
Journal:  J Infect Dis       Date:  2013-11-17       Impact factor: 5.226

Review 3.  Signaling Natural Products from Human Pathogenic Bacteria.

Authors:  Zhijuan Hu; Wenjun Zhang
Journal:  ACS Infect Dis       Date:  2019-10-30       Impact factor: 5.084

4.  A novel antimycobacterial compound acts as an intracellular iron chelator.

Authors:  Marte S Dragset; Giovanna Poce; Salvatore Alfonso; Teresita Padilla-Benavides; Thomas R Ioerger; Takushi Kaneko; James C Sacchettini; Mariangela Biava; Tanya Parish; José M Argüello; Magnus Steigedal; Eric J Rubin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 5.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

6.  Protein kinase A (PknA) of Mycobacterium tuberculosis is independently activated and is critical for growth in vitro and survival of the pathogen in the host.

Authors:  Sathya Narayanan Nagarajan; Sandeep Upadhyay; Yogesh Chawla; Shazia Khan; Saba Naz; Jayashree Subramanian; Sheetal Gandotra; Vinay Kumar Nandicoori
Journal:  J Biol Chem       Date:  2015-02-20       Impact factor: 5.157

7.  Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis.

Authors:  Zheng Liu; Feng Liu; Courtney C Aldrich
Journal:  J Org Chem       Date:  2015-06-16       Impact factor: 4.354

8.  Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes.

Authors:  Tony D Davis; Poornima Mohandas; Maria I Chiriac; Glennon V Bythrow; Luis E N Quadri; Derek S Tan
Journal:  Bioorg Med Chem Lett       Date:  2016-09-16       Impact factor: 2.823

9.  Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis.

Authors:  Surendra Dawadi; Kishore Viswanathan; Helena I Boshoff; Clifton E Barry; Courtney C Aldrich
Journal:  J Org Chem       Date:  2015-04-30       Impact factor: 4.354

10.  PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA.

Authors:  Michael V Tullius; Susana Nava; Marcus A Horwitz
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.